FDA Compliance - Clinical Research Informer

What Does Google’s Move to Responsive Search Ads for Paid Search Mean for Pharma?

Intouch Solutions

NOVEMBER 18, 2021

And educational resources have been created detailing the RSA ad format to share with the audiences who review creative assets for FDA compliance. Google will be changing its format for paid search campaigns. Let’s talk about what that means for pharma marketers!

FDA Compliance

FDA Compliance Branding Compliance Regulation

FDA Flips It and Reverses It: FDA Withdraws HHS Withdrawal of UDI Guidance

FDA Law Blog

JUNE 9, 2021

440.100, Marketed New Drugs Without Approved NDAs or ANDAs,” which set forth FDA’s approach to prioritizing enforcement actions and exercising enforcement discretion with respect to marketed unapproved drug products. Further, FDA assiduously defended the success of the UDI program.

Compliance

Compliance FDA Compliance Containment Production

Clinical Research Informer

What Does Google’s Move to Responsive Search Ads for Paid Search Mean for Pharma?

FDA Flips It and Reverses It: FDA Withdraws HHS Withdrawal of UDI Guidance

Webinars

Stay Connected